Does anyone have any insight into this headline on the first page of the presentation?
Could it be that this organisation https://www.iqvia.com/solutions/real-world-evidence/health-economics-and-value has been engaged by PNV to facilitate the early completion of the current BARDA trial by presenting market-specific evidence? Something that both Swami and DW have alluded to in the recent past.
Perhaps we can expect an announcement in September this year to this effect? Or am I reading too much into it?
Ann: Macquarie Australia Conference - Presentation, page-23
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.30 |
Change
-0.030(1.29%) |
Mkt cap ! $1.587B | |||
| Open | High | Low | Value | Volume |
| $2.38 | $2.38 | $2.29 | $2.291M | 989.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2733 | $2.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.31 | 19664 | 7 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |